Total 7 · Clear filters
Insilico Medicine listed on the Hong Kong Stock Exchange on 30 December 2025 under code 3696.HK, raising HKD 2.277 billion in what it called the largest Hong Kong biotech IPO of 2025 by funds raised.
On 6 November 2025 Mustafa Suleyman announced the MAI Superintelligence Team inside Microsoft AI. Its stated goal is "humanist superintelligence": problem-oriented AI with limits on autonomy that keeps humans in control.
In March 2025 Baichuan disbanded its financial-industry enterprise team and restructured to focus on AI for healthcare, later releasing the open medical models Baichuan-M2-32B and Baichuan-M3.
The 2024 Nobel Prize in Chemistry went to David Baker for computational protein design and, jointly, to Demis Hassabis and John Jumper of Google DeepMind for AI-based protein structure prediction. The Academy said their work solved a 50-year-old problem.
On 28 July 2022, DeepMind and EMBL-EBI expanded the AlphaFold Protein Structure Database from nearly 1 million to over 200 million predicted protein structures, covering nearly all catalogued proteins known to science.
On 14 January 2020, Keya Medical's Shenmai FFR software became the first AI medical device to receive a class III certificate in China, opening a registration path for diagnostic software and later reaching billable clinical use.
In June 2005 IBM and EPFL announced the Blue Brain Project, a two-year effort to model the neocortical column of a rodent on a Blue Gene supercomputer, launched by Henry Markram and backed by the Swiss Confederation.
